R. V. Andersen

Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.

B. Nordestgaard, P. Schnohr, A. Tybjaerg-hansen, 2003, Journal of the American College of Cardiology.

Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.

B. Nordestgaard, H. Sillesen, G. Jensen, 2009, The Journal of clinical endocrinology and metabolism.

Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.

B. Nordestgaard, G. Jensen, A. Tybjaerg-hansen, 2006, The Journal of clinical endocrinology and metabolism.

Hemochromatosis mutations in the general population: iron overload progression rate.

B. Nordestgaard, A. Tybjaerg-hansen, H. Birgens, 2004, Blood.

Sample-to-SNP kit: a reliable, easy and fast tool for the detection of HFE p.H63D and p.C282Y variations associated to hereditary hemochromatosis.

R. V. Andersen, P. B. Nielsen, Vibeke Blaabjerg, 2012, Gene.

Nanogen microelectronic chip for large-scale genotyping.

B. Nordestgaard, A. Tybjaerg-hansen, R. V. Andersen, 2004, Clinical chemistry.